
Toyobo acquires spain’s spinreact
Business Investments
01 Aug 2013
Toyobo has purchased 100% of the shares of spinreact, a catalan based company which manufactures in vitro diagnostic (ivd) reagents and instruments and markets these products through its global network. following the acquisition of spinreact, toyobo will substantially accelerate its strategy of overseas expansion in the field of biotechnology. spinreact has a network of dealers in approximately 90 countries around the world, covering not only spain but also africa, central and south america, europe, asia, and elsewhere as well as an extensive lineup of ivd-related products that have been adapted for use in the emerging country markets.
toyobo's objectives in acquiring spinreact as a wholly owned subsidiary are to utilize spinreact's global sales network in the field of ivd reagents and instruments, to expand its product lineup and to secure a production base in europe.
invest in catalonia has supported the project from its tokyo office.
source: toyobo, 1/8/2013
Related News and Success stories.
-
29 May 2025
Catalonia strengthens economic ties with Japan
-
26 May 2025
Catalonia promotes itself as a business investment hub during Catalan Week in Osaka
-
23 May 2025
Investing in Digital Health: Why Barcelona-Catalonia is on the Global Map
-
22 May 2025
Success Story: Why Roche Builds the Future of Digital Health from Barcelona